200 Years in the making
For years, the vaginal speculum has been the same clunky, cold, painful, invasive device as when it was first invented nearly 200 years ago.
NOT ANYMORE.
Meet Nella, the first redesign of the speculum to put the patient and clinician experience first, emphasizing comfort and ease of use.
NELLA IS A GAME CHANGER
The Nella Difference
At Ceek Women's Health, we believe a human-centered design approach leads to products that improve gynecological care for all.
Our Ceek product line includes the Nella, a redesigned vaginal speculum built for patient comfort which comes in a reusable speculum and a disposable speculum, the VuSleeve, an innovative single-use sheath, and the VuLight, a single-use LED illuminator.
a Note From Founder, Fahti Khosrowshahi
“10 years ago, I was on my seventh round of fertility treatments and millionth internal pelvic exam - each one using clunky metal speculums that caused me pain, bleeding and soreness. I knew there had to be a better way.
After some research, I discovered that the traditional metal speculum is close to 200 years old. Despite innovation in our cell phones, no one has considered the most fundamental aspect of women’s health. From then on, my mission was to develop a speculum that places women at the center of the exam experience. Every design choice, every material, and every silhouette is created by women for women, putting comfort, ease, and design first. In 2015, I launched Ceek Women’s Health to create innovative solutions for the modern woman and the modern world we live in.”
EXECUTIVE TEAM
As the founder of Ceek, Fahti drives the research and development with her personal mission to transform women’s care. Fahti gained 15 years of experience at Campbell Alliance, the largest pure-play consulting firm focused in life sciences. As the account lead for two of Campbell’s largest accounts, she eventually led the Global Account Business Unit and ended her Campbell career as the Global Commercial Strategy Practice Area Lead.
Fahti is a graduate of Middlebury College and has a Master’s degree in Business from Vanderbilt University. She is a mom to two girls and is active with the not-for-profit organization Child Foundation.org.
Tracy is the Chief Medical Officer at Ceek Women’s Health and is responsible for Clinical, Medical, Regulatory and Quality. She was employee #2 and has been with the company since it started in 2017. Tracy has 23 Years of Women’s Health Medical Device Experience. She was @ Welch Allyn for 17 years where she commercialized dozens of products ran their Women’s Health Division. Tracy obtained her MD and BS in Health Science from Saba University School of Medicine and a BS in Marketing and International Studies from State University of New York @ Oswego. She resides in Skaneateles, NY with her husband Rob, and is the proud mom of Aidan (24), Ashton (20) and Torin (17). Tracy is active in her local community, loves to travel, spend time on Skaneateles Lake and plays golf and tennis.
Allison Loughlin, appointed as Chief Marketing Officer (CMO), joins Ceek from INNOVO where she was also the CMO. INNOVO is a femmtech startup that accelerated significant growth in the urinary incontinence space. Holding a Master’s from Columbia University, Allison has decades of experience in women’s brands including such legacy companies as Victoria’s Secret, Lilly Pulitzer, and Estee Lauder.
Whitney has extensive experience in the women’s health and medical device fields launching products in large and small sized companies. Prior to joining Ceek, Whitney was the former Vice President of Sales for Hologic’s GYN Surgical Group, as well as SVP of Sales at Cognivue, Inc, where she strategically led both teams through significant growth and transformation. With over 25 years of commercial expertise she will be a tremendous asset to the team and we look forward to her leadership.
Sean joined Ceek Women’s Health in 2022 with a record of driving success in high-growth healthcareenvironments. Prior to Ceek, Sean was a Regional Vice President at Vein Clinics of America where he wasresponsible for scaling teams and improving efficiencies. Prior to acquisition by another healthcaregroup, Vein Clinics of America was a Private Equity-backed $300 Million specialty healthcare provider,operating 60 locations in 16 states, and impacting the lives of over 20,000 patients per year. Sean holds anMBA in Finance with a secondary emphasis in International Business, a Post-Graduate Certificate inExecutive Leadership, along with completing extensive prior medical coursework.
BOARD OF DIRECTORS
Wendy White has an impressive track record of building and growing emerging companies. She is a speaker, author and thought leader in rare disease. As the Board Director for Ceek she brings her unique expertise of patient-centered marketing and branding to the Ceek Nella line. She most recently worked as a Life Science Executive for Dohman Life Sciences (now Eversana) and Chief Patient Officer for Vitrisa Therapeutics. The digital marketing agency she founded and built, Siren Interactive, was eventually sold and integrated into Dohman Life Sciences (now Eversana). Wendy’s passion for rare disease patient advocacy and marketing let her to serve as Director at Large for the National Organization for Rare Disorders (NORD) where she helped launch rare disease day in the United States. She now serves as Director at Large for the International Collaboration on Rare Diseases and Orphan Drugs (ICORD). In 2022 Wendy was recognized with the prestigious Healthcare Businesswoman Association Strategic Transformation Achievement Recognition (STAR) Volunteer award.
Dr. Evantash has over two decades of experience working in medical and clinical affairs and brings a valuable clinical perspective to the Ceek Women’s Health board of directors. Dr. Evantash served as Medical Director and VP of Global Medical Affairs for Hologic and Chief Medical Officer for Alydia Health. After Alydia’s acquisition by Organon he co-founded BeSpoke Medical Affairs Solutions. Dr. Evantash received his medical degree from University of Pennsylvania School of Medicine as a Penn Scholar. He joined the faculty at Tufts University School of Medicine in Boston after finishing his residency at John Hopkins. At Tufts he was Division Chief of General Obstetrics and Gynecology.
Tom O’Neill has over 25 years of healthcare experience leading commercial operations, along with a proven track record in growing revenue while driving operational excellence and improving customer satisfaction. Mr. O’Neill currently serves as President and CEO of Cognivue, a pioneer in cognitive testing solutions. Before joining Cognivue, Mr. O’Neill served as President, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences, where he helped set the stage for long-term, sustainable growth. Prior to Qiagen, Tom served as the President for Hologic’s GYN, Surgical Solutions business, where he led the turnaround and significant top- and bottom-line growth for the division. Tom has a passion for women’s health and recognizes the significant unmet needs in this space.
Joel Schaider has served as General Counsel of Squadron Capital since January 2021. Prior to joining Squadron, Joel was a partner for 26 years at Reed Smith LLP. Joel has decades of experience in variety of corporate and finance transactions. Joel received a BS in Accountancy from Gies College of Business – University of Illinois at Urbana – Champaign, a JD and LLM-Taxation from Chicago – Kent College of Law and is a Certified Public Accountant.
